Cargando…
CD19( (+)) CD56( (–)) myeloma arising in a patient who failed two courses of immunosupressive therapy for aplastic anaemia
Patients diagnosed with severe aplastic anaemia and without a compatible bone marrow transplant donor are treated with immunosuppressive therapy. These patients are found with time to develop a clonal disease such as myelodysplasia or paroxysmal nocturnal haemoglobinuria. However, the development of...
Autores principales: | Murray, Nigel P, Ruiz, M Amparo, Miranda, G Maximiliano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336392/ https://www.ncbi.nlm.nih.gov/pubmed/28275389 http://dx.doi.org/10.3332/ecancer.2017.720 |
Ejemplares similares
-
Environmental contaminations and immunosupression
por: Ac̈aite, J., et al.
Publicado: (1995) -
To be or not to be: the role of CD56 in multiple myeloma
por: Cottini, Francesca, et al.
Publicado: (2023) -
Does type of immunosupression influence the course of Covid-19 infection?
por: Razanamahery, J., et al.
Publicado: (2020) -
APLASTIC ANAEMIA
Publicado: (1979) -
Pernicious Anæmia and Aplastic Anæmia
Publicado: (1925)